Case Studies

See real-life wins from our customers

Discover how our technology has supported drug developers and academic professionals in advancing the field of immunotherapies.

AML drug developer selects Teiko for 500+ specimen trial

First-in-class liver cancer immunotherapy developer picks Teiko

Multi-billion dollar AI drug developer streamlines sample collection and monitors immune response in Phase I trial with customized 40+ marker mass cytometry panel

Public immunotherapy developer uses 40+ parameter cytometry to uncover immune cells driving response in ~200 blood samples in Phase 1 study